Literature DB >> 23536655

Epstein-Barr virus negativity among individuals older than 60 years is associated with HLA-C and HLA-Bw4 variants and tonsillectomy.

Bojana Durovic1, Olivier Gasser, Patrick Gubser, Jörg Sigle, Hans H Hirsch, Martin Stern, Andreas Buser, Christoph Hess.   

Abstract

Epstein-Barr virus (EBV) infects ≈ 95% of the adult population. The factors that confer protection in the remaining ≈ 5% remain unknown. In an exploratory study, we assessed immunogenetic factors and tonsillectomy in a cohort of 17 EBV-negative and 39 EBV-positive healthy individuals aged >60 years. Analyses of HLA genotypes revealed an association between EBV negativity and the presence of HLA-C-35T/T and/or HLA-Bw4 alleles. In addition, EBV-negative donors presented with a history of tonsillectomy more often than EBV-positive donors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23536655      PMCID: PMC3648112          DOI: 10.1128/JVI.00169-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  Innate immunity: The unsung heroes.

Authors:  Peter Parham
Journal:  Nature       Date:  2003-05-01       Impact factor: 49.962

Review 2.  MHC class I molecules and KIRs in human history, health and survival.

Authors:  Peter Parham
Journal:  Nat Rev Immunol       Date:  2005-03       Impact factor: 53.106

3.  The immune response to primary EBV infection: a role for natural killer cells.

Authors:  Hilary Williams; Karen McAulay; Karen F Macsween; Neil J Gallacher; Craig D Higgins; Nadine Harrison; Anthony J Swerdlow; Dorothy H Crawford
Journal:  Br J Haematol       Date:  2005-04       Impact factor: 6.998

4.  Severe herpesvirus infections in an adolescent without natural killer cells.

Authors:  C A Biron; K S Byron; J L Sullivan
Journal:  N Engl J Med       Date:  1989-06-29       Impact factor: 91.245

5.  Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d.

Authors:  G R Nemerow; C Mold; V K Schwend; V Tollefson; N R Cooper
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

6.  Regulation of Epstein-Barr virus infection by recombinant interferons. Selected sensitivity to interferon-gamma.

Authors:  M Lotz; C D Tsoukas; S Fong; D A Carson; J H Vaughan
Journal:  Eur J Immunol       Date:  1985-05       Impact factor: 5.532

Review 7.  Epstein-Barr virus: 40 years on.

Authors:  Lawrence S Young; Alan B Rickinson
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

8.  Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay.

Authors:  H Kimura; M Morita; Y Yabuta; K Kuzushima; K Kato; S Kojima; T Matsuyama; T Morishima
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

9.  KIR-HLA and maternal-infant HIV-1 transmission in sub-Saharan Africa.

Authors:  Maria Paximadis; Gregory Minevich; Robert Winchester; Diana B Schramm; Glenda E Gray; Gayle G Sherman; Ashraf H Coovadia; Louise Kuhn; Caroline T Tiemessen
Journal:  PLoS One       Date:  2011-02-08       Impact factor: 3.240

Review 10.  Biology of natural killer cells.

Authors:  G Trinchieri
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

View more
  7 in total

1.  HLA-DQ β1 alleles associated with Epstein-Barr virus (EBV) infectivity and EBV gp42 binding to cells.

Authors:  Qingxue Li; Wei Bu; Erin Gabriel; Fiona Aguilar; Yo Hoshino; Hiroko Miyadera; Christoph Hess; Ronald L Hornung; Amitava Roy; Jeffrey I Cohen
Journal:  JCI Insight       Date:  2017-02-23

2.  Human Coronary Plaque T Cells Are Clonal and Cross-React to Virus and Self.

Authors:  Roshni Roy Chowdhury; Jessica D'Addabbo; Xianxi Huang; Stefan Veizades; Koki Sasagawa; David M Louis; Paul Cheng; Jan Sokol; Annie Jensen; Alexandria Tso; Vishnu Shankar; Ben Shogo Wendel; Isaac Bakerman; Grace Liang; Tiffany Koyano; Robyn Fong; Allison N Nau; Herra Ahmad; Jayakrishnan Gopakumar; Robert Wirka; Andrew S Lee; Jack Boyd; Y Joseph Woo; Thomas Quertermous; Gunsagar Singh Gulati; Siddhartha Jaiswal; Yueh-Hsiu Chien; Charles Kwok Fai Chan; Mark M Davis; Patricia K Nguyen
Journal:  Circ Res       Date:  2022-04-18       Impact factor: 23.213

Review 3.  Host genetics of Epstein-Barr virus infection, latency and disease.

Authors:  Charlotte J Houldcroft; Paul Kellam
Journal:  Rev Med Virol       Date:  2014-11-27       Impact factor: 6.989

4.  Host genetic variants and gene expression patterns associated with Epstein-Barr virus copy number in lymphoblastoid cell lines.

Authors:  Charlotte J Houldcroft; Velislava Petrova; Jimmy Z Liu; Dan Frampton; Carl A Anderson; Astrid Gall; Paul Kellam
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

5.  Predictors of Epstein-Barr virus serostatus and implications for vaccine policy: A systematic review of the literature.

Authors:  Joanne R Winter; Charlotte Jackson; Joanna Ea Lewis; Graham S Taylor; Olivia G Thomas; Helen R Stagg
Journal:  J Glob Health       Date:  2020-06       Impact factor: 4.413

6.  Epstein-Barr Virus and the Human Leukocyte Antigen Complex.

Authors:  Qingxue Li; Jeffrey I Cohen
Journal:  Curr Clin Microbiol Rep       Date:  2019-07-08

7.  CD56-negative NK cells with impaired effector function expand in CMV and EBV co-infected healthy donors with age.

Authors:  Bojana Müller-Durovic; Jasmin Grählert; Oliver P Devine; Arne N Akbar; Christoph Hess
Journal:  Aging (Albany NY)       Date:  2019-01-27       Impact factor: 5.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.